Interaction between neurotransmitter antagonists and effects of sacral neuromodulation in rats with chronically hyperactive bladder

BJU International

Volumn 96, Issue 6, 2005, Pages 900-908

  Riazimand, Seyed Hossein ^a   Mense, Siegfried ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Experimental cystitis; Glutamate; Nitric oxide; Sacral neuromodulation; Turpentine oil

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ANILIDE; GLUTAMIC ACID; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N NITRO ARGININE 4 NITROANILIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; TURPENTINE OIL; UNCLASSIFIED DRUG; URETHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CATHETERIZATION; BLADDER CONTRACTION; CEREBROSPINAL FLUID; CHRONIC DISEASE; CONTROLLED STUDY; CYSTITIS; DISEASE MODEL; ELECTRODE; LAMINECTOMY; NEUROMODULATION; NONHUMAN; OVERACTIVE BLADDER; PRESSURE TRANSDUCER; PRIORITY JOURNAL; RAT; RAT STRAIN; SACRAL SPINAL CORD; SPINAL CORD STIMULATION; SURVIVAL TIME;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANILIDES; ANIMALS; ARGININE; CHRONIC DISEASE; CYSTITIS; ELECTRIC STIMULATION; FEMALE; LUMBOSACRAL PLEXUS; MEMANTINE; MUSCLE CONTRACTION; NEUROTRANSMITTER AGENTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; URINARY INCONTINENCE;

EID: 25844437433     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05734.x     Document Type: Article

References (41)

1. Maher CF, Carey MP, Dwyer PL, Schluter PL. Percutaneous sacral nerve root neuromodulation for intractable interstitial cystitis. J Urol 2001; 165: 884-6
2. Shaker H, Hassouna MM. Sacral nerve root neuromodulation: an effective treatment for refractory urge incontinence. J Urol 1998; 159: 1516-9
3. Grünewald V, Höfner K, Thon WF, Kuczyk M, Jonas U. Sacral electrical neuromodulation as an alternative treatment option for lower urinary tract dysfunction. Restor Neurol Neurosci 1999; 14: 189-93
4. DasGupta R, Fowler CJ. Urodynamic study of women in urinary retention treated with sacral neuromodulation. J Urol 2004; 171: 1161-4
5. Pettit PD, Thompson JR, Chen AH. Sacral neuromodulation: new applications in the treatment of female pelvic floor dysfunction. Curr Opin Obstet Gynecol 2002; 14: 521-5
6. Feler CA, Whitworth LA, Fernandez J. Sacral neuromodulation for chronic pain conditions. Anesthesiol Clin North Am 2003; 21: 785-95
7. Hassouna MM, Elmayergi N, Abdelhady M. Update on sacral neuromodulation: indications and outcomes. Curr Urol Rep 2003: 391-8
8. Tai C, Booth AM, de Groat WC, Roppolo JR. Bladder and urethral sphincter responses evoked by microstimulation of S2 sacral spinal cord in spinal cord intact and chronic spinal cord injured cats. Exp Neurol 2004; 190: 171-83
9. Weil EH, Ruiz-Cerda JL, Eerdmans PH, Janknegt RA, van Kerrebroeck PE. Clinical results of sacral neuromodulation for chronic voiding dysfunction using unilateral sacral foramen electrodes. World J Urol 1998; 16: 313-21
10. Ruud Bosch JI, Groen J. Sacral nerve neuromodulation in the treatment of refractory motor urge incontinence. Curr Opin Urol 2001; 11: 399-403
11. Shaker H, Wang Y, Loung D, Balbaa L, Fehlings MG, Hassouna MM. Role of C-afferent fibres in the mechanism of sacral nerve root neuromodulation in chronic spinal cord injury. BJU Int 2000; 85: 905-10
12. Zvara P, Sahi S, Hassouna MM. An animal model for the neuromodulation of neurogenic bladder dysfunction. Br J Urol 1998; 82: 267-71
13. Wang Y, Zhou Y, Mourad MS, Hassouna MM. Neuromodulation reduces urinary frequency in rats with hydrochloric acid-induced cystitis. BJU Int 2000; 86: 726-30
14. Zhou Y, Wang Y, Abdelhady M, Mourad MS, Hassouna MM. Change of vanilloid receptor 1 following neuromodulation in rats with spinal cord injury. J Surg Res 2002; 107: 140-4
15. Dinis P, Charrua A, Avelino A et al. Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis. J Neurosci 2004; 24: 11253-63
16. Maggi CA, Guiliani S, Giachetti A, Meli A. The effect of MK-801 on the micturition reflex in anesthetized rats. Eur J Pharmacol 1990; 181: 105-9
17. Yoshiyama M, Roppolo JR, Thor KB, de Groat WC. Effects of LY27461, a competitive NMDA receptor antagonist, on the micturition reflex in the urethane-anesthetized rat. Br J Pharmacol 1993; 110: 77-86
18. Ishida F, Sato T, Imaizumi M, et al. MK-801 inhibits the micturition reflex in chronic bladder irritation caused by crystalluria in the rat. Auton Neurosci 2003; 30: 1-7
19. Vizzard MA, Erdman SL, deGroat WC. Increased expression of neuronal nitric oxide synthase in bladder afferent pathways following chronic bladder irritation. J Comp Neurol 1996; 370: 191-202
20. Callsen-Cencic P, Mense S. Expression of neuropeptides and nitric oxide synthase in neurones innervating the inflamed rat urinary bladder. J Auton Nerv Syst 1997; 65: 33-44
21. Millan MJ. The induction of pain: an integrative review. Prog Neurobiol 1999; 57: 1-164
22. Harris JA, Corsi M, Quartaroli M, Arban R, Bentivoglio M. Upregulation of spinal glutamate receptors in chronic pain. Neuroscience 1996; 74: 7-12
23. Bettler B, Mulle C. Review: neurotransmitter receptors. II. AMPA and kainate receptors. Neuropharmacology 1995; 34: 123-39
24. Baranauskas G, Nistri A. Sensitization of pain pathways in the spinal cord: cellular mechanisms. Progr Neurobiol 1998; 54: 349-65
25. Rice AS. Topical spinal administration of a nitric oxide synthase inhibitor prevents the hyper-reflexia associated with a rat model of persistent visceral pain. Neurosci Lett 1995; 187: 111-4
26. Noda K, Takebe M, Oka M, Hirouchi M, Ukai Y, Toda N. Functional role of inhibitory and excitatory nerves in the porcine lower urinary tract. Eur J Pharmacol 2002; 456: 81-90
27. Sutherland RS, Kogan BA, Piechota HJ, Bredt DS. Vesicourethral function in mice with genetic disruption of neuronal nitric oxide synthase. J Urol 1997; 157: 1109-16
28. Headley M. NMDA antagonists: unequal to the task or unequal to each other - or both? Eur J Pain 1999; 3: 185-7
29. Parsons CG, Dynysz E, Quack G. Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - a review of preclinical data. Neuropharmacology 1999; 38: 735-67
30. Riazimand SH, Mense S. A rat model for studying effects of sacral neuromodulation on the contractile activity of a chronically inflamed bladder. BJU Int 2004; 94: 158-63
31. Häbler HJ, Jänig W, Koltzenburg M. Receptive properties of myelinated primary afferents innervating the inflamed urinary bladder of the cat. J Neurophysiol 1993; 69: 395-405
32. Johnson OL, Berkley KJ. Estrous influences on micturition thresholds of the female rat before and after bladder inflammation. Am J Physiol Regul Integr Comp Physiol 2002; 282: R289-94
33. Braun PM, Seif C, Scheepe JR et al. Chronic sacral bilateral neuromodulation. Using a minimal invasive implantation technique in patients with disorders of bladder function. Urologe 2002; 41: 44-7
34. de Groat WC, Booth AM, Yoshimura N. Neurophysiology of micturition and its modification in animal models of human disease. In Maggi CA ed. The Autonomic Nervous System: Vol. 2 Nervous Control of the Urogenital System. London: Hartwood Academic Publishers, 1992: 227-90
35. Vera PL, Nadelhaft I. MK-801, a non-competitive NMDA receptor antagonist, produces facilitation of the micturition reflex in awake, freely-moving rats. Neurosci Lett 1991; 134: 135-8
36. Herrero JF, Headley PM, Parsons CG. Memantine selectively depresses NMDA receptor-mediated responses of rat spinal neurones in vivo. Neurosci Lett 1994; 165: 37-40
37. Carlton SM, Rees H, Tsuruoka M, Willis WD. Memantine attenuates responses of spinothalamic tract cells to cutaneous stimulation in neuropathic monkeys. Eur J Pain 1998; 2: 229-38
38. Yokoyama O, Yoshiyama M, Namiki M, de Groat WC. Influence of anesthesia on bladder hyperactivity induced by middle cerebral artery occlusion in the rat. Am J Physiol 1997; 273: R1900-7
39. Kawatani M, Erdman SL, de Groat WC. Vasoactive intestinal polypeptide and substance P in primary afferent pathways to the sacral spinal cord of the cat. J Comp Neurol 1985; 241: 327-47
40. Sharkey KA, Williams RG, Schultzberg M, Dockray GJ. Sensory substance P-innervation of the urinary bladder: possible site of action of capsaicin in causing urine retention in rats. Neuroscience 1983; 10: 861-8
41. Lamb K, Gebhart GG, Bielefeldt K. Increased nerve growth factor expression triggers bladder overactivity. J Pain 2004; 5: 150-6